Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 10Plasma cell 1Lymphoid 1CNS 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1Granuloma, Plasma Cell 1

Interventions

Cyclophosphamide 345Rituximab 309Vincristine 160Doxorubicin 157venetoclax 156fludarabine 153Specimen Handling 152Prednisone 152Biopsy 122obinutuzumab 117Magnetic Resonance Spectroscopy 117Lenalidomide 110Dexamethasone 106Cytarabine 100ibrutinib 96Etoposide 94fludarabine phosphate 87Methotrexate 86acalabrutinib 79zanubrutinib 73Bendamustine Hydrochloride 73pembrolizumab 63blinatumomab 63CT-P10 61Gemcitabine 52glofitamab 45Nivolumab 45Calcium Dobesilate 45Mercaptopurine 44prednylidene 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
brigatinib × Lymphoid × 1 year × Clear all
NCT04925609 2025-12-05

Briga-PED

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
65 enrolled
LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡